Spectrum of 18F-FDG Uptake in Bilateral Lung Parenchymal Diseases on PET/CT

被引：17

作者：

Prabhu, Meghana ^{[1
]}

Raju, Shobhana ^{[1
]}

Chakraborty, Dhritiman ^{[1
]}

Arora, Saurabh ^{[1
]}

Kumar, Rakesh ^{[1
]}

机构：

[1] AIIMS, Dept Nucl Med, New Delhi, India

来源：

CLINICAL NUCLEAR MEDICINE | 2020年 / 45卷 / 01期

关键词：

bilateral lung parenchymal disease; F-18-FDG uptake PET/CT;

D O I：

10.1097/RLU.0000000000002758

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Bilateral lung parenchymal involvement is seen in infective as well as noninfective conditions, appearing as focal or diffuse lung disease. PET/CT with FDG helps in characterization (increased glucose utilization is seen by both inflammatory and neoplastic cells). In this article, we describe the spectrum of patterns of FDG uptake and associated CT changes involving bilateral lung parenchyma. Benign conditions described are aspiration pneumonia; pulmonary toxicity by bleomycin; infections, namely, sarcoidosis, miliary pulmonary tuberculosis, and pulmonary nocardiosis; and inflammatory conditions such as pulmonary Langerhans cell histiocytosis and pulmonary alveolar proteinosis. Neoplastic conditions described are bilateral pulmonary metastases and lymphangitic carcinomatosis.

引用

页码：E15 / E19

页数：5

共 9 条

[1] Role of 18F-FDG PET/CT in patients affected by Langerhans cell histiocytosis [J].